Introduction. Several studies have suggested, that diabetes is very important factor of the risk of the chronic a renal disease. The paper aims to present a retrospective analysis of incidence of end-stage renal disease in subgroups of patients with and without diabetes in Poland. Material and methods. For assessing this problem an electronic search was performed using Polish National Health Fund data base from 01.01.2011 until 31.12.2013 in general population and from 01.01.2012 until 31.12.2012 in 2 populations: with diabetes and without diabetes mellitus. Results. The 43.70 % patients with end-stage renal disease was diabetic. The incidence rate in 2012 was: 292.48 ± 90.97 diabetic men / 100,000 diabetic population; 203.10 ± 90.97 diabetic women / 100,000 diabetic population; 23.44 ± 6.34 non-diabetic men / 100,000 non-diabetic population; 17.88 ± 6.33 non-diabetic women / 100,000 non-diabetic population. Conclusions. The incidence rate of end-stage renal failure in diabetics was multiple times higher than the incidence rate in non-diabetics. The incidence rate of new ESRD cases in Poland estimated to be 36.17 per 100,000 of general populations in 2011, 35.28% in 2012 and 30.46 per 100,000 of general populations in 2013. In 2012, the incidence rate of new ESRD cases in male diabetics was 292.48 ± 90.97 per 100,000 of diabetes men population, and in women diabetics 203.10 ± 66.06 per 100,000 of diabetes women population. In the same 2012 year, the incidence of new ESRD cases in men non-diabetics was 3.44 ± 6.34 per 100,000 of non-diabetes, and in women non-diabetes 17.58 ± 6.33 per 100,000 of non-diabetes women population.
INTRODUCTION
In 2010, end-stage renal disease (also called: ESRD or endstage renal failure) was the cause of renal replacement therapy for 2,618,000 people worldwide [1] . The exact number of patients with ESRD remains unknown -the disease is unpredictable, increasingly widespread, causes significant problems for the patients and generates enormous costs of medical treatment. ESRD is defined by Kidney Disease Improving Global Outcomes (KDIGO) as a glomerular filtration rate (eGFR) reduced below 15 ml/min/1.73 m² which lasts for 3 months or longer-and is referred to as stage 5 chronic kidney disease (G5) [2] . In their meta-analysis of 100 scientific reports from all around the world, which covered 6,908,440 people in total, Mill et al. show that chronic kidney disease (CKD) affects 13.4% of the world population [3] . Stage 1 of CKD (G1) is present in 3.5% of the population, stage 2 (G2) in 3.9%, stage 3 (G3) in 7.6%, stage 4 (G4) in 0.4%, and stage 5 (G5) in 0.1% [3] .
The main risk factors for CKD include diabetes, hypertension, and kidney diseases [4] . The glomerular filtration rate progressively decreases with aging [4] . CKD increases the risk of death and cardiovascular events [5] , is the reason of frequent hospitalizations [1, 2] , exacerbates cognitive impairment [6] and decreases the quality of life [7] .
In this publication, the accumulated data was retrospectively analyzed for the incidence of new ESRD cases in patients with and without diabetes. The data on both subpopulations in Poland in 2012 was acquired from the National Health Fund database.
Objectives. The paper aims to present a retrospective analysis of incidence of end-stage renal disease in subgroups of patients with and without diabetes in Poland. Our retrospective analysis was constricted by inability to assess the causes of ESRD, the type of diabetes the patients had, and their metabolic control. The foreground ESRD diagnosis could have reduced the number of patients. In addition, the analysis could not determine if the diabetes was the cause of ESRD. Instead, the analysis showed cases of ESRD diagnosis in diabetics.
MATERIAL AND METHODS
Health services in Poland are funded by National Health Fund (NHF -a third-party payer) under the Act of and the regulations of the Ministry of Health arising therefrom [8, 9, 10] . The health services for diabetics in Poland are provided within the framework of both in-patient (hospitalization) and out-patient health care. The organization of those services is specified in the orders of the President of the National Health Fund [11, 12] .
The data related to patient's personal identification number (PESEL) and to services on kidney failure marked according to ICD-10 (N18.0) [13] was extracted from the database on provided health services. The analysis was conducted for the years 2011-2013. In 2011, 2012, 2013, ESRD incidence rate for the general population were analyzed. In addition, in 2012, incidence rate of ESRD were analyzed for two subpopulations: diabetic and non-diabetic patients. Then, the data related to the patients with ICD-10 records with diabetes as a primary diagnosis was extracted: E10.X -Insulin-dependent diabetes mellitus, E11.X -Non-insulin-dependent diabetes mellitus, E12.X -Malnutrition-related diabetes mellitus, E13.XOther specified diabetes mellitus, E14.X -Unspecified diabetes mellitus. We also extracted the data on patients who reportedly filled their prescription for any of drugs from the group A10A.X (insulins) or A10B.X (oral anti-diabetic agents) and specialized diagnostic tests. All patients who received a refund for diabetes in 2012 were included. Date were obtained and prepared using the following tools: Structured Query Language and SAS software by SAS Institute. T-student test of independence were used. Differences were considered to be significant at the significance level of 95% (P<0.05). Table 1 shows the number of patients with ESRD in Poland in 2011, 2012 and 2013, broken down by gender (according to the National Health Fund database).
RESULTS

Demographic data
In 2011, there were 13,925 new patients with ESRD in the NHF database, including 9,625 men and 6,300 women; in 2012 there were 13,593 new patients found, including 7,287 men and 6,306 women, and in 2013 there were 11,815 new patients -6,289 men and 5,526 women. In the observed period, men constituted 53.23% -54.76% of the patients, while women made up from 45.24% to 47%.
According to data from the Central Statistical Office (GUS), in 2011 Poland covered a population of 38,501,000 people, of whom 18, 432 The average age of patients with and without diabetes in both groups was significantly higher for women, (P<0.001). A comparison of the average age of men and women in both groups showed that the average age of both genders is significantly higher in the group of patients with recognized diabetes (diabetic versus without diabetic patients, at P<0.001).
The number of diabetic patients in Poland in 2012 amounted to 2,227,453 -975,364 men and 1,252,089 women. On the other hand, the population of Poland without diabetes was 36,306, 323, including 17,676,027 men and 18,625,254 women.
The incidence was based on NHF database and estimated to be in the years 2011, 2012, 2013. Table 3 shows the incidence of ESRD per 100,000 people in Poland in the years 2011-2013 (according to the National Health Fund), presented with a division based on gender.
The annual incidence of ESRD for both genders in Poland in the years 2011-2013 ranged from 33.76 to 41.37 per 100,000. The annual incidence of ESRD in men in the years 2011-2013 ranged from 33.76 to 41.37 per 100,000. The annual incidence of ESRD in women in the years 2011-2013 ranged from 27.41 to 31.49 per 100,000.
Comparison of the ESRD incidence in Poland, in patients with and without diabetes. In diabetics under 44 years of age, the ESRD incidence was observed in 4.31% men and 4.43% women, while among patients without diabetes in the same age group the percentages were 16.24% and 19.43% for men and women, respectively. For the age group of 45-64, the ESRD incidence in non-diabetic male patients was twice as high. The ESRD incidence in men diabetics aged 65 or more was 79.1%, while in non-diabetic men it was 49.31%. In women over 65, however, this percentage was 74.32% for diabetics and 58.87% for non-diabetics. Table 5 compiles the incidence of new ESRD cases in patients with and without diabetes per 100,000 people, after extracting the number of patients with recognized diabetes.
The ESRD incidence in men with recognized diabetes in Poland in 2012 was 12 times higher than in non-diabetics, with P<0.001.
Similarly, the ESRD incidence in women with recognized diabetes in Poland in 2012 was 11.5 times higher than in non-diabetics, with P<0.001.
In 2012, the incidence of end-stage renal disease in men was significantly higher in comparison to the incidence of end-stage renal disease in women, in both diabetic and nondiabetic patients, at P<0.001. Table 6 presents new ESRD cases in 2012 in people with recognized diabetes per 100,000 diabetics, and in people without recognized diabetes per 100,000 population after subtracting the number of diabetics, broken down by NHF regional branches and gender of the patients.
Particular attention was paid to, is the ESRD incidence in male diabetics higher than the average for the whole country in the following provinces: Wielkopolskie, Świętokrzyskie, Warmińsko-Mazurskie, Śląskie, Podkarpackie, Mazowieckie and Zachodnio-Pomorskie.
In female with diabetes, the incidence rate of ESRD higher than the average for the whole country was found in provinces: Warmińsko-Mazurskie, Wielkopolskie, Śląskie, Opolskie and Mazowieckie.
The ESRD incidence rate higher than the average for the whole country was found in the following provinces: Wielkopolskie, Warmińsko-Mazurskie, ZachodnioPomorskie, Mazowieckie, Opolskie and Podkarpackie.
In women without diabetes, however, the ESRD incidence rate higher than the average for the whole country was found in the following provinces: Wielkopolskie, Warmińsko-Mazurskie, Zachodnio-Pomorskie and Świętokrzyskie.
This data must be interpreted with caution, for there is a possibility that, in example, the wards with more ESRD cases simply have better diagnostics. This problem may need further particular investigation.
DISCUSSION
According to our reports, the percentage of people with ESRD in the general population varies between 0.03% and 0.04%, while Mill et al. in their meta-analysis claim it is 0.1% [3] . The conducted analysis was a retrospective study based on the National Health Fund data from the years 2011-2013, with included reports on hospitalizations and out-patient services in Poland.
The ESRD incidence in Poland is relatively wellcharacterized and described and, according to Polish authors, is similar to that in Western Europe countries [14, 15] . In the conducted study we analyzed new ESRD cases in people with and without recognized diabetes. The average age of diabetic patients was significantly higher than non-diabetic ones, regardless of gender. The average age of patients with diabetes was 67.73±12.69 years for men and 65.07±17.47 years for women. The average age of women, both diabetics and non-diabetics, was significantly higher than the average age of men, at P<0.001. 
